Huntington’s disease research news.
In plain language. Written by scientists.
For the global HD community.
Novartis have announced that they are ending development of the drug branaplam in Huntington’s disease. Here, we review this latest news and its impact on the HD community.
New to HD research? Click here to get an overview
A Freedom Tower on Chromosome Five
Subscribe in iTunes
Podcast RSS Feed
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can't promise to write content about any particular suggestion.